詳細検索

詳細検索

×

キーワード検索の使い方

×
A
B
C
D
E
F
G
H
I
J
L
M
O
P
Q
R
S
T
U
V
W
X
日

お問い合わせ

タンパク質受託製造市場レポート：2026-2036

タンパク質受託製造市場レポート：2026-2036


Protein Contract Manufacturing Market Report 2026-2036

説明 Visiongainは、新たなレポート『2026-2036年 タンパク質受託製造市場レポート』を発表しました。 世界のタンパク質受託製造市場は、2026年に133.1億米ドルの規模となり、予測期間中は年平均成長... もっと見る

　

　

出版社
Visiongain
ヴィジョンゲイン社
出版年月
2026年10月10日
電子版価格
GBP5,150
部署ライセンス
ライセンス・価格情報／注文方法はこちら
納期
2営業日程度
ページ数
358
言語
英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

説明

Visiongainは、新たなレポート『2026-2036年 タンパク質受託製造市場レポート』を発表しました。 世界のタンパク質受託製造市場は、2026年に133.1億米ドルの規模となり、予測期間中は年平均成長率（CAGR）9.7％で拡大し、2036年には336.2億米ドルに達すると予測されています。

本レポートでは、市場規模、成長要因、競合状況、および事業規模、サービス、発現系、タンパク質の種類、治療領域、エンドユーザーセグメントごとの売上予測など、市場に関する包括的な分析を提供しています。

タンパク質系バイオ医薬品の開発・製造におけるアウトソーシングの拡大

製薬会社やバイオテクノロジー企業は、資本要件の削減、専門的なノウハウの活用、そして変化する生産ニーズへの対応を図るため、タンパク質の開発・製造を外部委託する傾向が強まっています。社内にバイオ医薬品製造施設を構築するには、多額の投資、経験豊富な人材、バリデーション済みのプロセス、そして継続的な規制順守が必要となります。 CDMOは、臨床規模から商業規模に至るまで、哺乳類および微生物を用いた生産能力へのアクセスを提供しており、開発企業は専用の施設を建設することなく、開発プログラムを推進することが可能になります。

ロンザ社の報告によると、大小を問わずバイオ医薬品企業が外部の製造パートナーへの依存度を高めていることから、CDMOの生産能力は顧客が所有する施設の生産能力を上回り続けているという。 アウトソーシングは、商業インフラをまだ整備していない新興のバイオテクノロジー企業や、追加の生産能力、地域ごとの生産体制、供給の柔軟性を求める老舗製薬企業にとって特に重要である。また、このモデルにより、スポンサー企業は自社の製造ネットワークを完全に置き換えるのではなく、それを補完することが可能になる。タンパク質製造のアウトソーシングは、単なる生産能力不足への一時的な対応にとどまらず、長期的な事業戦略としてますます定着しつつある。

レポートの範囲とデータの対象範囲

  • 世界のタンパク質受託製造市場の分析
  • 2036年までの売上高予測と年間成長率の見通し
  • 6つのセグメンテーションフレームワークにわたるセグメントレベルのモデリング
  • 5つの地域および14の主要国内市場にわたる地域別・国内市場の予測
  • 主要企業17社に関する競合情報

技術、競合状況、貿易動向、サプライチェーンの動向などを網羅した、定量的な予測と定性的な戦略分析の両方を含んでいます。

350ページにわたる本報告書には、136の表と197の図表・グラフが掲載されています。

セグメンテーションの枠組み

事業規模別

  • 前臨床／臨床
  • コマーシャル

サービス別

  • タンパク質原薬の製造
  • タンパク質医薬品の製造
  • 開発・分析サービス

エクスプレッションシステム別

  • 哺乳類
  • 微生物
  • その他

タンパク質タイプ別

  • モノクローナル抗体および抗体断片
  • 融合タンパク質
  • 酵素
  • ホルモンと成長因子
  • サイトカインとインターフェロン
  • その他

治療領域別

  • 腫瘍学
  • 自己免疫疾患および炎症性疾患
  • 代謝性疾患
  • 心血管疾患
  • 感染症
  • その他の治療領域

エンドユーザー別

  • 製薬会社
  • バイオテクノロジー企業
  • バイオシミラーメーカー
  • 学術・研究機関

対象地域

北米

  • アメリカ合衆国
  • カナダ

欧州

  • ドイツ
  • イギリス
  • フランス
  • イタリア
  • その他の欧州地域

アジア太平洋地域

  • 日本
  • 中国
  • インド
  • オーストラリア
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ

中東・アフリカ

  • GCC
  • 南アフリカ
  • その他の中東・アフリカ地域

企業情報に関する報道

本レポートには、以下を含む17社の主要企業の詳細なプロフィールが掲載されています：

  • Abzena
  • 3P BIOVIAN
  • AGC Biologics
  • Boehringer Ingelheim BioXcellence
  • Curia Global, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza Group AG
  • Catalent, Inc. (Novo Holdings)
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics Co., Ltd.
  • Syngene International Limited
  • Thermo Fisher Scientific Inc. (Patheon Pharma Services)
  • Wacker Biotech GmbH
  • WuXi Biologics

各プロフィールには以下の内容が含まれています：

  • 事業概要
  • 財務および市場における位置づけ
  • 技術ロードマップとプログラムの成果
  • 戦略的展望

主な疑問への回答

  • タンパク質受託製造市場はどのように変化しているのでしょうか？
  • タンパク質受託製造市場を牽引し、抑制している要因は何でしょうか？
  • 予測期間において、各サブマーケットセグメントはどのように成長し、2036年にはこれらのサブマーケットが売上高のどの程度の割合を占めることになるのでしょうか？
  • 2026年から2036年にかけて、各サブマーケットの市場シェアはどのように推移するでしょうか？
  • 主要なタンパク質受託製造市場は、概してマクロ経済の動向に追随するのでしょうか、それとも個々の国の市場が他を凌ぐパフォーマンスを示すのでしょうか？
  • 主要企業はどの企業であり、予測期間におけるその見通しはどのようなものか？
  • 2026年から2036年にかけて、この業界はどのように変化していくのでしょうか？


お問い合わせ

お問合せ種類／内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る


目次

1 レポートの概要
1.1 本調査の目的
1.2 タンパク質受託製造市場の概要
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問：
1.6 本レポートの対象読者
1.7 調査方法
1.7.1 市場の定義
1.7.2 市場評価および予測の方法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 二次調査
1.8 よくある質問（FAQ）
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 概要

3 市場の概要
3.1 主な調査結果
3.2 影響分析
3.3 市場を牽引する要因
3.4 市場を抑制する要因
3.5 市場機会
3.6 ポーターの5つの力分析
3.6.1 供給者の交渉力
3.6.2 購入者の交渉力
3.6.3 競合他社間の競争
3.6.4 代替品の脅威
3.6.5 新規参入の脅威
3.7 PEST分析
3.8 米国の関税：世界のタンパク質受託製造市場に与える影響は？
3.8.1 概要
3.8.2 V字型回復シナリオ
3.8.2.1 なぜV字型回復なのか？
3.8.2.2 関税による影響
3.8.2.3 市場の動向と需要の回復
3.8.2.4 政策および資金支援
3.8.2.5 回復までの期間
3.9 U字型回復シナリオ
3.9.1.1 なぜU字型回復なのか？
3.9.1.2 関税による影響
3.9.1.3 市場の動向と需要の回復
3.9.1.4 政策および資金面での支援
3.9.1.5 回復までの期間
3.10 L字型回復シナリオ
3.10.1.1 なぜL字型回復なのか？
3.10.1.2 関税による影響
3.10.1.3 市場の動向と需要の回復
3.10.1.4 政策および資金面での支援
3.10.1.5 回復までの期間
3.11 顧客は、短期（2026～2031年）および長期（2026～2036年）の計画において、どのような戦略的考慮事項を織り込むべきか？
3.12 米国と中国の貿易戦争がタンパク質受託製造市場に与える影響
3.13 最も影響を受ける国々は、これらの政策変更によってどのようなプラスおよびマイナスの影響を受ける可能性があるか？

4 タンパク質受託製造市場の分析：事業規模別（百万米ドル、年平均成長率（AGR）％）
4.1 主な調査結果
4.2 事業規模セグメント：市場魅力度指数
4.3 前臨床／臨床
4.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
4.3.2 地域別市場シェア（2026年および2036年）（％）
4.4 市販段階
4.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
4.4.2 地域別市場シェア、2026年および2036年（％）

5 タンパク質受託製造市場の分析：サービス別（百万米ドル、年平均成長率（AGR）％）
5.1 主な調査結果
5.2 サービスセグメント：市場魅力度指数
5.3 タンパク質原薬の製造
5.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.3.2 地域別市場シェア、2026年および2036年（％）
5.4 タンパク質医薬品の製造
5.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.4.2 地域別市場シェア、2026年および2036年（％）
5.5 開発および分析サービス
5.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.5.2 地域別市場シェア、2026年および2036年（％）

6 タンパク質受託製造市場の分析：エクスプレッションシステム別（百万米ドル、年平均成長率（AGR）％）
6.1 主な調査結果
6.2 エクスプレッション・システムセグメント：市場魅力度指数
6.3 哺乳類
6.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
6.3.2 地域別市場シェア、2026年および2036年（％）
6.4 微生物
6.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
6.4.2 地域別市場シェア、2026年および2036年（％）
6.5 その他
6.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
6.5.2 地域別市場シェア、2026年および2036年（％）

7 タンパク質受託製造市場の分析：タンパク質タイプ別（単位：百万米ドル、年平均成長率（AGR）％）
7.1 主な調査結果
7.2 タンパク質タイプ別セグメント：市場魅力度指数
7.3 モノクローナル抗体および抗体断片
7.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.3.2 地域別市場シェア、2026年および2036年（％）
7.4 融合タンパク質
7.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
7.4.2 地域別市場シェア、2026年および2036年（％）
7.5 酵素
7.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.5.2 地域別市場シェア、2026年および2036年（％）
7.6 ホルモンおよび成長因子
7.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.6.2 地域別市場シェア、2026年および2036年（％）
7.7 サイトカインおよびインターフェロン
7.7.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.7.2 地域別市場シェア、2026年および2036年（％）
7.8 その他
7.8.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.8.2 地域別市場シェア、2026年および2036年（％）

8 タンパク質受託製造市場の分析：治療領域別（単位：百万米ドル、年平均成長率（AGR）％）
8.1 主な調査結果
8.2 治療領域別セグメント：市場魅力度指数
8.3 オンコロジー
8.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.3.2 地域別市場シェア、2026年および2036年（％）
8.4 自己免疫疾患および炎症性疾患
8.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.4.2 地域別市場シェア、2026年および2036年（％）
8.5 代謝性疾患
8.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.5.2 地域別市場シェア、2026年および2036年（％）
8.6 心血管疾患
8.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.6.2 地域別市場シェア、2026年および2036年（％）
8.7 感染症
8.7.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.7.2 地域別市場シェア、2026年および2036年（％）
8.8 その他の治療領域
8.8.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.8.2 地域別市場シェア、2026年および2036年（％）

9 タンパク質受託製造市場の分析：エンドユーザー別（単位：百万米ドル、年平均成長率（AGR）％）
9.1 主な調査結果
9.2 エンドユーザー別セグメント：市場魅力度指数
9.3 製薬企業
9.3.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.3.2 地域別市場シェア、2026年および2036年（％）
9.4 バイオテクノロジー企業
9.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.4.2 地域別市場シェア、2026年および2036年（％）
9.5 バイオシミラーメーカー
9.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.5.2 地域別市場シェア、2026年および2036年（％）
9.6 学術・研究機関
9.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
9.6.2 地域別市場シェア、2026年および2036年（％）

10 タンパク質受託製造市場分析：地域別
10.1 主な調査結果
10.2 地域別市場規模の推計と予測

11 北米のタンパク質受託製造市場分析
11.1 主な調査結果
11.2 北米タンパク質受託製造市場の魅力度指数
11.3 北米タンパク質受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
11.4 北米タンパク質受託製造市場の規模推計および予測：国別
11.5 北米タンパク質受託製造市場の規模推計および予測：事業規模別
11.6 北米タンパク質受託製造市場の規模推計および予測：サービス別
11.7 北米タンパク質受託製造市場の規模推計および予測：エクスプレッション・システム別
11.8 北米タンパク質受託製造市場の規模推計および予測：タンパク質タイプ別
11.9 北米タンパク質受託製造市場の規模推計および予測：治療領域別
11.10 北米タンパク質受託製造市場の規模推計および予測：エンドユーザー別
11.11 米国タンパク質受託製造市場の分析
11.12 カナダタンパク質受託製造市場の分析

12 欧州のタンパク質受託製造市場分析
12.1 主な調査結果
12.2 欧州タンパク質受託製造市場の魅力度指数
12.3 欧州タンパク質受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
12.4 欧州タンパク質受託製造市場の規模推計および予測：国別）
12.5 欧州タンパク質受託製造市場の規模推計および予測：事業規模別）
12.6 欧州タンパク質受託製造市場の規模推計および予測：サービス別
12.7 欧州タンパク質受託製造市場の規模推計および予測：エクスプレッション・システム別
12.8 欧州タンパク質受託製造市場の規模推計および予測：タンパク質タイプ別
12.9 欧州タンパク質受託製造市場規模の推計および予測：治療領域別
12.10 欧州タンパク質受託製造市場規模の推計および予測：エンドユーザー別
12.11 ドイツのタンパク質受託製造市場の分析
12.12 英国のタンパク質受託製造市場の分析
12.13 フランスのタンパク質受託製造市場の分析
12.14 イタリアのタンパク質受託製造市場の分析
12.15 その他の欧州地域のタンパク質受託製造市場の分析

13 アジア太平洋地域のタンパク質受託製造市場の分析
13.1 主な調査結果
13.2 アジア太平洋地域のタンパク質受託製造市場の魅力度指数
13.3 アジア太平洋地域のタンパク質受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
13.4 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：国別
13.5 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：事業規模別
13.6 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：サービス別
13.7 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：エクスプレッション・システム別
13.8 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：タンパク質のタイプ別
13.9 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：治療領域別
13.10 アジア太平洋地域のタンパク質受託製造市場規模の推計および予測：エンドユーザー別
13.11 日本のタンパク質受託製造市場の分析
13.12 中国のタンパク質受託製造市場の分析
13.13 インドのタンパク質受託製造市場の分析
13.14 オーストラリアのタンパク質受託製造市場の分析
13.15 その他のアジア太平洋地域のタンパク質受託製造市場の分析

14 ラテンアメリカのタンパク質受託製造市場分析
14.1 主な調査結果
14.2 ラテンアメリカンパク質受託製造市場の魅力度指数
14.3 ラテンアメリカタンパク質受託製造市場（国別、2026年、2031年、2036年）（百万米ドル）
14.4 ラテンアメリカタンパク質受託製造市場の規模推計および予測：国別
14.5 ラテンアメリカタンパク質受託製造市場の規模推計および予測：事業規模別
14.6 ラテンアメリカタンパク質受託製造市場の規模推計および予測：サービス別
14.7 ラテンアメリカタンパク質受託製造市場の規模推計および予測：エクスプレッション・システム別
14.8 ラテンアメリカタンパク質受託製造市場の規模推計および予測：タンパク質タイプ別
14.9 ラテンアメリカタンパク質受託製造市場の規模推計および予測：治療領域別
14.10 ラテンアメリカタンパク質受託製造市場の規模推計および予測：エンドユーザー別
14.11 ブラジルにおけるタンパク質受託製造市場の分析
14.12 メキシコにおけるタンパク質受託製造市場の分析
14.13 その他のラテンアメリカ地域のタンパク質受託製造市場の分析

15 MEAタンパク質受託製造市場の分析
15.1 主な調査結果
15.2 MEAタンパク質受託製造市場の魅力度指数
15.3 MEAタンパク質受託製造市場規模：国別、2026年、2031年、2036年（百万米ドル）
15.4 MEAタンパク質受託製造市場規模の推計および予測：国別
15.5 MEAタンパク質受託製造市場規模の推計および予測：事業規模別
15.6 MEAタンパク質受託製造市場規模の推計および予測：サービス別
15.7 MEAタンパク質受託製造市場規模の推計および予測：エクスプレッション・システム別
15.8 MEAタンパク質受託製造市場規模の推計および予測：タンパク質タイプ別
15.9 MEAタンパク質受託製造市場規模の推計および予測：治療領域別
15.10 MEA タンパク質受託製造市場の規模推計および予測：エンドユーザー別
15.11 GCC タンパク質受託製造市場の分析
15.12 南アフリカ タンパク質受託製造市場の分析
15.13 その他の MEA タンパク質受託製造市場の分析

16社の企業概要
16.1 Abzena
16.1.1 企業概要
16.1.2 会社概要
16.1.3 財務状況
16.1.3.1 売上高、2022年～2025年（百万米ドル）
16.1.3.2 研究開発費、2022年～2025年（百万米ドル）
16.1.3.3 事業セグメント別市場シェア（％）、2025年
16.1.3.4 地域別市場シェア（％）、2025年
16.1.4 サービスベンチマーキング
16.1.5 戦略的展望
16.2 3P BIOVIAN
16.2.1 企業概要
16.2.2 企業概要
16.2.3 財務状況
16.2.3.1 売上高、2022年～2025年（百万米ドル）
16.2.3.2 研究開発費、2022年～2025年 （百万米ドル）
16.2.3.3 事業セグメント別市場シェア（％）、2025年
16.2.3.4 地域セグメント別市場シェア（％）、2025年
16.2.4 サービスのベンチマーク
16.2.5 戦略的展望
16.3 AGC Biologics
16.3.1 企業概要
16.3.2 会社概要
16.3.3 財務状況
16.3.3.1 売上高、2022年～2025年（百万米ドル）
16.3.3.2 研究開発費、2022年～2025年（百万米ドル）
16.3.3.3 事業セグメント別市場シェア（％）、2025年
16.3.3.4 地域セグメント別市場シェア（％）、2025年
16.3.4 サービスベンチマーキング
16.3.5 戦略的展望
16.4 ベーリンガーインゲルハイム・バイオエクセレンス
16.4.1 企業概要
16.4.2 会社概要
16.4.3 企業の財務状況
16.4.3.1 売上高、2022年～2025年（百万米ドル）
16.4.3.2 研究開発費、2022年～2025年（百万米ドル）
16.4.3.3 事業セグメント別市場シェア（％）、2025年
16.4.3.4 地域セグメント別市場シェア（％）、2025年
16.4.4 サービスベンチマーキング
16.4.5 戦略的展望
16.5 Curia Global, Inc.
16.5.1 企業概要
16.5.2 会社概要
16.5.3 財務状況
16.5.3.1 売上高、2022年～2025年（百万米ドル）
16.5.3.2 研究開発費、2022年～2025年（百万米ドル）
16.5.3.3 事業セグメント別市場シェア（％）、2025年
16.5.3.4 地域別市場シェア（％）、2025年
16.5.4 サービスのベンチマーク
16.5.5 戦略的展望
16.6 Cytovance Biologics
16.6.1 企業概要
16.6.2 会社概要
16.6.3 財務状況
16.6.3.1 売上高、2022年～2025年（百万米ドル）
16.6.3.2 研究開発費、2022年～2025年 （百万米ドル）
16.6.3.3 事業セグメント別市場シェア（％）、2025年
16.6.3.4 地域セグメント別市場シェア（％）、2025年
16.6.4 サービスベンチマーキング
16.6.5 戦略的展望
16.7 富士フイルム・ディオシンズ・バイオテクノロジーズ
16.7.1 企業概要
16.7.2 会社概要
16.7.3 財務状況
16.7.3.1 売上高、2022年～2025年（百万米ドル）
16.7.3.2 研究開発費、2022年～2025年（百万米ドル）
16.7.3.3 事業セグメント別市場シェア（％）、2025年
16.7.3.4 地域セグメント別市場シェア（％）、2025年
16.7.4 サービスベンチマーキング
16.7.5 戦略的展望
16.8 KBI Biopharma
16.8.1 企業概要
16.8.2 会社概要
16.8.3 財務状況
16.8.3.1 売上高、2022年～2025年（百万米ドル）
16.8.3.2 研究開発費、2022年～2025年（百万米ドル）
16.8.3.3 事業セグメント別市場シェア（％）、2025年
16.8.3.4 地域別市場シェア（％）、2025年
16.8.4 サービスベンチマーキング
16.8.5 戦略的展望
16.9 ロンザ・グループAG
16.9.1 企業概要
16.9.2 会社概要
16.9.3 財務状況
16.9.3.1 売上高、2022年～2025年（百万米ドル）
16.9.3.2 研究開発費、2022年～2025年 （百万米ドル）
16.9.3.3 事業セグメント別市場シェア（％）、2025年
16.9.3.4 地域セグメント別市場シェア（％）、2025年
16.9.4 サービスベンチマーキング
16.9.5 戦略的展望
16.10 カタレント社（Novo Holdings）
16.10.1 企業概要
16.10.2 会社概要
16.10.3 財務状況
16.10.3.1 売上高、2022年～2025年（百万米ドル）
16.10.3.2 研究開発費、2022年～2025年（百万米ドル）
16.10.3.3 事業セグメント別市場シェア（％）、2025年
16.10.3.4 地域セグメント別市場シェア（％）、2025年
16.10.4 サービスのベンチマーキング
16.10.5 戦略的展望
16.11 ProBioGen AG
16.11.1 企業概要
16.11.2 会社概要
16.11.3 財務状況
16.11.3.1 売上高、2022年～2025年（百万米ドル）
16.11.3.2 研究開発費、2022年～2025年（百万米ドル）
16.11.3.3 事業セグメント別市場シェア（％）、2025年
16.11.3.4 地域セグメント別市場シェア（％）、2025年
16.11.4 サービスのベンチマーキング
16.11.5 戦略的展望
16.12 Rentschler Biopharma SE
16.12.1 企業概要
16.12.2 会社概要
16.12.3 企業の財務状況
16.12.3.1 売上高、2022年～2025年（百万米ドル）
16.12.3.2 研究開発費、2022年～2025年（百万米ドル）
16.12.3.3 事業セグメント別市場シェア（％）、2025年
16.12.3.4 地域セグメント別市場シェア（％）、2025年
16.12.4 サービスのベンチマーク
16.12.5 戦略的展望
16.13 サムスン・バイオロジクス株式会社
16.13.1 企業概要
16.13.2 会社概要
16.13.3 財務状況
16.13.3.1 売上高、2022年～2025年（百万米ドル）
16.13.3.2 研究開発費、2022年～2025年 （百万米ドル）
16.13.3.3 事業セグメント別市場シェア（％）、2025年
16.13.3.4 地域セグメント別市場シェア（％）、2025年
16.13.4 サービスのベンチマーク
16.13.5 戦略的展望
16.14 Syngene International Limited
16.14.1 企業概要
16.14.2 会社概要
16.14.3 財務状況
16.14.3.1 売上高、2022年～2025年（百万米ドル）
16.14.3.2 研究開発費、2022年～2025年（百万米ドル）
16.14.3.3 事業セグメント別市場シェア（％）、2025年
16.14.3.4 地域セグメント別市場シェア（％）、2025年
16.14.4 サービスのベンチマーキング
16.14.5 戦略的展望
16.15 サーモフィッシャーサイエンティフィック社（パテオン・ファーマ・サービス）
16.15.1 企業概要
16.15.2 会社概要
16.15.3 企業の財務状況
16.15.3.1 売上高、2022年～2025年（百万米ドル）
16.15.3.2 研究開発費、2022年～2025年（百万米ドル）
16.15.3.3 事業セグメント別市場シェア（％）、2025年
16.15.3.4 地域セグメント別市場シェア（％）、2025年
16.15.4 サービスのベンチマーク
16.15.5 戦略的展望
16.16 ワッカー・バイオテック社（Wacker Biotech GmbH）
16.16.1 企業概要
16.16.2 会社概要
16.16.3 企業の財務状況
16.16.3.1 売上高、2022年～2025年（百万米ドル）
16.16.3.2 研究開発費、2022年～2025年（百万米ドル）
16.16.3.3 事業セグメント別市場シェア（％）、2025年
16.16.3.4 地域セグメント別市場シェア（％）、2025年
16.16.4 サービスのベンチマーク
16.16.5 戦略的展望
16.17 ウーシー・バイオロジクス
16.17.1 企業概要
16.17.2 会社概要
16.17.3 企業の財務状況
16.17.3.1 売上高、2022年～2025年（百万米ドル）
16.17.3.2 研究開発費、2022年～2025年（百万米ドル）
16.17.3.3 事業セグメント別市場シェア（％）、2025年
16.17.3.4 地域セグメント別市場シェア（％）、2025年
16.17.4 サービスベンチマーキング
16.17.5 戦略的展望

17 結論と提言
17.1 Visiongainによる総括
17.2 市場関係者への提言

 

ページTOPに戻る



図表リスト

List of Tables
Table 1 Protein Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 3 Preclinical / Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 4 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 5 Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 6 Protein Drug Substance Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 7 Protein Drug Product Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 8 Development and Analytical Services Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 9 Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 10 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 11 Microbial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 12 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 13 Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 14 Monoclonal Antibodies and Antibody Fragments Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 15 Fusion Proteins Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 16 Enzymes Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 17 Hormones and Growth Factors Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 18 Cytokines and Interferons Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 20 Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 21 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 22 Autoimmune and Inflammatory Disorders Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 23 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 24 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 25 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 26 Other Therapeutic Area Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 27 Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 28 Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 29 Biotechnology Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 30 Biosimilar Manufacturers Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 31 Academic and Research Institutions Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 32 Protein Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 33 North America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 34 North America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 35 North America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 36 North America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 37 North America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 38 North America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 39 North America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 40 U.S. Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 41 Canada Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 42 Europe Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 43 Europe Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 44 Europe Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 45 Europe Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 46 Europe Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 47 Europe Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 48 Europe Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 49 Germany Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 50 UK Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 51 France Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 52 Italy Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 53 Rest of Europe Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 54 Asia Pacific Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 55 Asia Pacific Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 56 Asia Pacific Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 57 Asia Pacific Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 58 Asia Pacific Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 59 Asia Pacific Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 60 Asia Pacific Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 61 Japan Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 62 China Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 63 India Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 64 Australia Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 65 Rest of Asia Pacific Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 66 Latin America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 67 Latin America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 68 Latin America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 69 Latin America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 70 Latin America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 71 Latin America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 72 Latin America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 73 Brazil Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 74 Mexico Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 75 Rest of Latin America Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 76 MEA Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 77 MEA Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 78 MEA Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 79 MEA Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 80 MEA Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 81 MEA Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 82 MEA Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 83 GCC Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 84 South Africa Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 85 Rest of MEA Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 86 Abzena: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Abzena: Service Benchmarking
Table 88 Abzena: Strategic Outlook
Table 89 3P BIOVIAN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 3P BIOVIAN: Service Benchmarking
Table 91 3P BIOVIAN: Strategic Outlook
Table 92 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 AGC Biologics: Service Benchmarking
Table 94 AGC Biologics: Strategic Outlook
Table 95 Boehringer Ingelheim BioXcellence: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Boehringer Ingelheim BioXcellence: Service Benchmarking
Table 97 Boehringer Ingelheim BioXcellence: Strategic Outlook
Table 98 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Curia Global, Inc.: Service Benchmarking
Table 100 Curia Global, Inc.: Strategic Outlook
Table 101 Cytovance Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Cytovance Biologics: Service Benchmarking
Table 103 Cytovance Biologics: Strategic Outlook
Table 104 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 106 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 107 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 KBI Biopharma: Service Benchmarking
Table 109 KBI Biopharma: Strategic Outlook
Table 110 Lonza Group AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Lonza Group AG: Service Benchmarking
Table 112 Lonza Group AG: Strategic Outlook
Table 113 Catalent, Inc. (Novo Holdings): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Catalent, Inc. (Novo Holdings): Service Benchmarking
Table 115 Catalent, Inc. (Novo Holdings): Strategic Outlook
Table 116 ProBioGen AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 ProBioGen AG: Service Benchmarking
Table 118 ProBioGen AG: Strategic Outlook
Table 119 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Rentschler Biopharma SE: Service Benchmarking
Table 121 Rentschler Biopharma SE: Strategic Outlook
Table 122 Samsung Biologics Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Samsung Biologics Co., Ltd.: Service Benchmarking
Table 124 Samsung Biologics Co., Ltd.: Strategic Outlook
Table 125 Syngene International Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Syngene International Limited: Service Benchmarking
Table 127 Syngene International Limited: Strategic Outlook
Table 128 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Service Benchmarking
Table 130 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Strategic Outlook
Table 131 Wacker Biotech GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Wacker Biotech GmbH: Service Benchmarking
Table 133 Wacker Biotech GmbH: Strategic Outlook
Table 134 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 WuXi Biologics: Service Benchmarking
Table 136 WuXi Biologics: Strategic Outlook

List of Figures
Figure 1 Protein Contract Manufacturing Market Segmentation
Figure 2 Protein Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
Figure 3 Protein Contract Manufacturing Market by Service: Market Attractiveness Index
Figure 4 Protein Contract Manufacturing Market by Expression System: Market Attractiveness Index
Figure 5 Protein Contract Manufacturing Market by Protein Type: Market Attractiveness Index
Figure 6 Protein Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
Figure 7 Protein Contract Manufacturing Market by End-users: Market Attractiveness Index
Figure 8 Protein Contract Manufacturing Market Attractiveness Index by Region
Figure 9 Protein Contract Manufacturing Market: Market Dynamics
Figure 10 Protein Contract Manufacturing Market: Porter’s Five Forces Analysis
Figure 11 Protein Contract Manufacturing Market: PEST Analysis
Figure 12 Protein Contract Manufacturing Market Attractiveness Index by Scale of Operation
Figure 13 Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 14 Protein Contract Manufacturing Market Share Forecast by Scale of Operation, 2026, 2031, 2036 (%)
Figure 15 Preclinical / Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 16 Preclinical / Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 17 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 18 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 19 Protein Contract Manufacturing Market Attractiveness Index by Service
Figure 20 Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 21 Protein Contract Manufacturing Market Share Forecast by Service, 2026, 2031, 2036 (%)
Figure 22 Protein Drug Substance Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 23 Protein Drug Substance Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Protein Drug Product Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 25 Protein Drug Product Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Development and Analytical Services Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 27 Development and Analytical Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 28 Protein Contract Manufacturing Market Attractiveness Index by Expression System
Figure 29 Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 30 Protein Contract Manufacturing Market Share Forecast by Expression System, 2026, 2031, 2036 (%)
Figure 31 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 32 Mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Microbial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 34 Microbial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 36 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Protein Contract Manufacturing Market Attractiveness Index by Protein Type
Figure 38 Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 39 Protein Contract Manufacturing Market Share Forecast by Protein Type, 2026, 2031, 2036 (%)
Figure 40 Monoclonal Antibodies and Antibody Fragments Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 41 Monoclonal Antibodies and Antibody Fragments Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 42 Fusion Proteins Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 43 Fusion Proteins Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Enzymes Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 45 Enzymes Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Hormones and Growth Factors Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 47 Hormones and Growth Factors Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Cytokines and Interferons Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 49 Cytokines and Interferons Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Protein Contract Manufacturing Market Attractiveness Index by Therapeutic Area
Figure 53 Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 54 Protein Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026, 2031, 2036 (%)
Figure 55 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 56 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Autoimmune and Inflammatory Disorders Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 58 Autoimmune and Inflammatory Disorders Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 60 Metabolic Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 62 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 63 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 64 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 65 Other Therapeutic Area Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 66 Other Therapeutic Area Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 67 Protein Contract Manufacturing Market Attractiveness Index by End-users
Figure 68 Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 69 Protein Contract Manufacturing Market Share Forecast by End-users, 2026, 2031, 2036 (%)
Figure 70 Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 71 Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 72 Biotechnology Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 73 Biotechnology Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 74 Biosimilar Manufacturers Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 75 Biosimilar Manufacturers Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 76 Academic and Research Institutions Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 77 Academic and Research Institutions Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 78 Protein Contract Manufacturing Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR %)
Figure 79 Protein Contract Manufacturing Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 80 Protein Contract Manufacturing Market by Region, 2026-2036 (US$ Bn, AGR %)
Figure 81 North America Protein Contract Manufacturing Market Attractiveness Index
Figure 82 North America Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 83 North America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 84 North America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 85 North America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 86 North America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 87 North America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 88 North America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 89 North America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 90 U.S. Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 91 Canada Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 92 Europe Protein Contract Manufacturing Market Attractiveness Index
Figure 93 Europe Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 94 Europe Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 95 Europe Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 96 Europe Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 97 Europe Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 98 Europe Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 99 Europe Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 100 Europe Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 101 Germany Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 102 UK Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 103 France Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 104 Italy Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 105 Rest of Europe Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 106 Asia Pacific Protein Contract Manufacturing Market Attractiveness Index
Figure 107 Asia Pacific Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 108 Asia Pacific Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 109 Asia Pacific Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 110 Asia Pacific Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 111 Asia Pacific Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 112 Asia Pacific Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 113 Asia Pacific Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 114 Asia Pacific Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 115 Japan Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 116 China Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 117 India Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 118 Australia Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 119 Rest of Asia Pacific Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 120 Latin America Protein Contract Manufacturing Market Attractiveness Index
Figure 121 Latin America Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 122 Latin America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 123 Latin America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 124 Latin America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 125 Latin America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 126 Latin America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 127 Latin America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 128 Latin America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 129 Brazil Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 130 Mexico Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 131 Rest of Latin America Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 132 MEA Protein Contract Manufacturing Market Attractiveness Index
Figure 133 MEA Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 134 MEA Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 135 MEA Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 136 MEA Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 137 MEA Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 138 MEA Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 139 MEA Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 140 MEA Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 141 GCC Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 142 South Africa Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 143 Rest of MEA Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 144 Abzena: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 145 Abzena: Regional Market Shares (%), 2025
Figure 146 Abzena: R&D, 2022-2025 (US$ Million, AGR %)
Figure 147 Abzena: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 148 Abzena: Regional Market Shares (%), 2025
Figure 149 Abzena: R&D, 2022-2025 (US$ Million, AGR %)
Figure 150 3P BIOVIAN: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 151 3P BIOVIAN: Regional Market Shares (%), 2025
Figure 152 3P BIOVIAN: R&D, 2022-2025 (US$ Million, AGR %)
Figure 153 AGC Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 154 AGC Biologics: Regional Market Shares (%), 2025
Figure 155 AGC Biologics: R&D, 2022-2025 (US$ Million, AGR %)
Figure 156 Boehringer Ingelheim BioXcellence: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 157 Boehringer Ingelheim BioXcellence: Regional Market Shares (%), 2025
Figure 158 Boehringer Ingelheim BioXcellence: R&D, 2022-2025 (US$ Million, AGR %)
Figure 159 Curia Global, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 160 Curia Global, Inc.: Regional Market Shares (%), 2025
Figure 161 Curia Global, Inc.: R&D, 2022-2025 (US$ Million, AGR %)
Figure 162 Cytovance Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 163 Cytovance Biologics: Regional Market Shares (%), 2025
Figure 164 Cytovance Biologics: R&D, 2022-2025 (US$ Million, AGR %)
Figure 165 FUJIFILM Diosynth Biotechnologies: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 166 FUJIFILM Diosynth Biotechnologies: Regional Market Shares (%), 2025
Figure 167 FUJIFILM Diosynth Biotechnologies: R&D, 2022-2025 (US$ Million, AGR %)
Figure 168 KBI Biopharma: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 169 KBI Biopharma: Regional Market Shares (%), 2025
Figure 170 KBI Biopharma: R&D, 2022-2025 (US$ Million, AGR %)
Figure 171 Lonza Group AG: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 172 Lonza Group AG: Regional Market Shares (%), 2025
Figure 173 Lonza Group AG: R&D, 2022-2025 (US$ Million, AGR %)
Figure 174 Catalent, Inc. (Novo Holdings): Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 175 Catalent, Inc. (Novo Holdings): Regional Market Shares (%), 2025
Figure 176 Catalent, Inc. (Novo Holdings): R&D, 2022-2025 (US$ Million, AGR %)
Figure 177 ProBioGen AG: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 178 ProBioGen AG: Regional Market Shares (%), 2025
Figure 179 ProBioGen AG: R&D, 2022-2025 (US$ Million, AGR %)
Figure 180 Rentschler Biopharma SE: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 181 Rentschler Biopharma SE: Regional Market Shares (%), 2025
Figure 182 Rentschler Biopharma SE: R&D, 2022-2025 (US$ Million, AGR %)
Figure 183 Samsung Biologics Co., Ltd.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 184 Samsung Biologics Co., Ltd.: Regional Market Shares (%), 2025
Figure 185 Samsung Biologics Co., Ltd.: R&D, 2022-2025 (US$ Million, AGR %)
Figure 186 Syngene International Limited: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 187 Syngene International Limited: Regional Market Shares (%), 2025
Figure 188 Syngene International Limited: R&D, 2022-2025 (US$ Million, AGR %)
Figure 189 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 190 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Regional Market Shares (%), 2025
Figure 191 Thermo Fisher Scientific Inc. (Patheon Pharma Services): R&D, 2022-2025 (US$ Million, AGR %)
Figure 192 Wacker Biotech GmbH: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 193 Wacker Biotech GmbH: Regional Market Shares (%), 2025
Figure 194 Wacker Biotech GmbH: R&D, 2022-2025 (US$ Million, AGR %)
Figure 195 WuXi Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 196 WuXi Biologics: Regional Market Shares (%), 2025
Figure 197 WuXi Biologics: R&D, 2022-2025 (US$ Million, AGR %)

 

　

ページTOPに戻る


　

Summary

Description

Visiongain has published a new report, Protein Contract Manufacturing Market Report 2026-2036. The global protein contract manufacturing market is valued at US$13.31bn in 2026 and is forecast to reach US$33.62bn by 2036, at a CAGR of 9.7% over the forecast period.

This report provides a comprehensive analysis of the market including market size, growth drivers, competitive positioning, and revenue forecasts across scale of operation, service, expression system, protein type, therapeutic area, and end-user segments.

Increasing Outsourcing of Protein Biologics Development and Manufacturing

Pharmaceutical and biotechnology companies are increasingly outsourcing protein development and manufacturing to reduce capital requirements, access specialised expertise and accommodate changing production needs. Establishing an internal biologics facility requires substantial investment, experienced personnel, validated processes and continuing regulatory compliance. CDMOs provide access to mammalian and microbial production capabilities across clinical and commercial scales, allowing developers to advance programmes without constructing dedicated facilities.

Lonza has reported that CDMO capacity continues to outpace capacity in customer-owned facilities, as both large and small biopharmaceutical companies increasingly rely on external manufacturing partners. Outsourcing is particularly important for emerging biotechnology companies without commercial infrastructure and established pharmaceutical companies seeking additional capacity, regional production and supply flexibility. The model also enables sponsors to complement internal manufacturing networks rather than replacing them completely. Protein manufacturing outsourcing is increasingly becoming a long-term operating strategy rather than solely a temporary response to capacity shortages.

Report Scope and Data Coverage

  • Global protein contract manufacturing market analysis
  • Revenue forecasts to 2036 with annual growth estimates
  • Segment-level modelling across six segmentation frameworks
  • Regional and national market forecasts across five regions and 14 leading national markets
  • Competitive intelligence on 17 leading companies

Includes both quantitative forecasting and qualitative strategic analysis covering technology, competition, trade dynamics, and supply chain developments.

Our 350-page report provides 136 tables and 197 charts/graphs.

Segmentation Framework

By Scale of Operation

  • Preclinical / Clinical
  • Commercial

By Service

  • Protein Drug Substance Manufacturing
  • Protein Drug Product Manufacturing
  • Development and Analytical Services

By Expression System

  • Mammalian
  • Microbial
  • Others

By Protein Type

  • Monoclonal Antibodies and Antibody Fragments
  • Fusion Proteins
  • Enzymes
  • Hormones and Growth Factors
  • Cytokines and Interferons
  • Others

By Therapeutic Area

  • Oncology
  • Autoimmune and Inflammatory Disorders
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Therapeutic Areas

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Biosimilar Manufacturers
  • Academic and Research Institutions

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of MEA

Company Intelligence Coverage

This report includes detailed profiles of 17 leading companies, including:

  • Abzena
  • 3P BIOVIAN
  • AGC Biologics
  • Boehringer Ingelheim BioXcellence
  • Curia Global, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza Group AG
  • Catalent, Inc. (Novo Holdings)
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics Co., Ltd.
  • Syngene International Limited
  • Thermo Fisher Scientific Inc. (Patheon Pharma Services)
  • Wacker Biotech GmbH
  • WuXi Biologics

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Technology roadmap and programme wins
  • Strategic outlook

Key Questions Answered

  • How is the protein contract manufacturing market evolving?
  • What is driving and restraining the protein contract manufacturing market?
  • How will each submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2036?
  • How will the market shares for each submarket develop from 2026 to 2036?
  • Will leading protein contract manufacturing markets broadly follow macroeconomic dynamics, or will individual national markets outperform others?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2026 and 2036?

 



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Protein Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Impact Analysis
3.3 Market Driving Factors
3.4 Market Restraining Factors
3.5 Market Opportunities
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Threat of Substitutes
3.6.5 Threat of New Entrants
3.7 PEST Analysis
3.8 U.S. Tariffs: What’s the Impact on Global Protein Contract Manufacturing Market?
3.8.1 Overview
3.8.2 V-Shaped Recovery Scenario
3.8.2.1 Why V-Shaped Recovery?
3.8.2.2 Impact from Tariffs
3.8.2.3 Market Dynamics and Demand Recovery
3.8.2.4 Policy and Funding Support
3.8.2.5 Timeframe for Recovery
3.9 U-Shaped Recovery Scenario
3.9.1.1 Why U-Shaped Recovery?
3.9.1.2 Impact from Tariffs
3.9.1.3 Market Dynamics and Demand Recovery
3.9.1.4 Policy and Funding Support
3.9.1.5 Timeframe for Recovery
3.10 L-Shaped Recovery Scenario
3.10.1.1 Why L-Shaped Recovery?
3.10.1.2 Impact from Tariffs
3.10.1.3 Market Dynamics and Demand Recovery
3.10.1.4 Policy and Funding Support
3.10.1.5 Timeframe for Recovery
3.11 What Strategic Considerations Should Clients Factor into Their Near-term (2026–2031) and Long-term (2026–2036) Planning?
3.12 Impact of U.S. and China Trade War on Protein Contract Manufacturing Market
3.13 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?

4 Protein Contract Manufacturing Market Analysis by Scale of Operation (US$ Million, AGR %)
4.1 Key Findings
4.2 Scale of Operation Segment: Market Attractiveness Index
4.3 Preclinical / Clinical
4.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
4.3.2 Market Share by Region, 2026 & 2036 (%)
4.4 Commercial
4.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2026 & 2036 (%)

5 Protein Contract Manufacturing Market Analysis by Service (US$ Million, AGR %)
5.1 Key Findings
5.2 Service Segment: Market Attractiveness Index
5.3 Protein Drug Substance Manufacturing
5.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.3.2 Market Share by Region, 2026 & 2036 (%)
5.4 Protein Drug Product Manufacturing
5.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2026 & 2036 (%)
5.5 Development and Analytical Services
5.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2026 & 2036 (%)

6 Protein Contract Manufacturing Market Analysis by Expression System (US$ Million, AGR %)
6.1 Key Findings
6.2 Expression System Segment: Market Attractiveness Index
6.3 Mammalian
6.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.3.2 Market Share by Region, 2026 & 2036 (%)
6.4 Microbial
6.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Others
6.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2026 & 2036 (%)

7 Protein Contract Manufacturing Market Analysis by Protein Type (US$ Million, AGR %)
7.1 Key Findings
7.2 Protein Type Segment: Market Attractiveness Index
7.3 Monoclonal Antibodies and Antibody Fragments
7.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.3.2 Market Share by Region, 2026 & 2036 (%)
7.4 Fusion Proteins
7.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Enzymes
7.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Hormones and Growth Factors
7.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.6.2 Market Share by Region, 2026 & 2036 (%)
7.7 Cytokines and Interferons
7.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.7.2 Market Share by Region, 2026 & 2036 (%)
7.8 Others
7.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.8.2 Market Share by Region, 2026 & 2036 (%)

8 Protein Contract Manufacturing Market Analysis by Therapeutic Area (US$ Million, AGR %)
8.1 Key Findings
8.2 Therapeutic Area Segment: Market Attractiveness Index
8.3 Oncology
8.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.3.2 Market Share by Region, 2026 & 2036 (%)
8.4 Autoimmune and Inflammatory Disorders
8.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.4.2 Market Share by Region, 2026 & 2036 (%)
8.5 Metabolic Diseases
8.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.5.2 Market Share by Region, 2026 & 2036 (%)
8.6 Cardiovascular Diseases
8.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.6.2 Market Share by Region, 2026 & 2036 (%)
8.7 Infectious Diseases
8.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.7.2 Market Share by Region, 2026 & 2036 (%)
8.8 Other Therapeutic Area
8.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.8.2 Market Share by Region, 2026 & 2036 (%)

9 Protein Contract Manufacturing Market Analysis by End-users (US$ Million, AGR %)
9.1 Key Findings
9.2 End-users Segment: Market Attractiveness Index
9.3 Pharmaceutical Companies
9.3.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.3.2 Market Share by Region, 2026 & 2036 (%)
9.4 Biotechnology Companies
9.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.4.2 Market Share by Region, 2026 & 2036 (%)
9.5 Biosimilar Manufacturers
9.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.5.2 Market Share by Region, 2026 & 2036 (%)
9.6 Academic and Research Institutions
9.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.6.2 Market Share by Region, 2026 & 2036 (%)

10 Protein Contract Manufacturing Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Protein Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 North America Protein Contract Manufacturing Market Attractiveness Index
11.3 North America Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
11.4 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Country
11.5 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
11.6 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Service
11.7 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
11.8 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
11.9 North America Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
11.10 North America Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
11.11 U.S. Protein Contract Manufacturing Market Analysis
11.12 Canada Protein Contract Manufacturing Market Analysis

12 Europe Protein Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 Europe Protein Contract Manufacturing Market Attractiveness Index
12.3 Europe Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
12.4 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
12.6 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Service
12.7 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
12.8 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
12.9 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
12.10 Europe Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
12.11 Germany Protein Contract Manufacturing Market Analysis
12.12 UK Protein Contract Manufacturing Market Analysis
12.13 France Protein Contract Manufacturing Market Analysis
12.14 Italy Protein Contract Manufacturing Market Analysis
12.15 Rest of Europe Protein Contract Manufacturing Market Analysis

13 Asia Pacific Protein Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 Asia Pacific Protein Contract Manufacturing Market Attractiveness Index
13.3 Asia Pacific Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
13.4 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Country
13.5 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
13.6 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Service
13.7 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
13.8 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
13.9 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
13.10 Asia Pacific Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
13.11 Japan Protein Contract Manufacturing Market Analysis
13.12 China Protein Contract Manufacturing Market Analysis
13.13 India Protein Contract Manufacturing Market Analysis
13.14 Australia Protein Contract Manufacturing Market Analysis
13.15 Rest of Asia Pacific Protein Contract Manufacturing Market Analysis

14 Latin America Protein Contract Manufacturing Market Analysis
14.1 Key Findings
14.2 Latin America Protein Contract Manufacturing Market Attractiveness Index
14.3 Latin America Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
14.4 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Country
14.5 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
14.6 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Service
14.7 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
14.8 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
14.9 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
14.10 Latin America Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
14.11 Brazil Protein Contract Manufacturing Market Analysis
14.12 Mexico Protein Contract Manufacturing Market Analysis
14.13 Rest of Latin America Protein Contract Manufacturing Market Analysis

15 MEA Protein Contract Manufacturing Market Analysis
15.1 Key Findings
15.2 MEA Protein Contract Manufacturing Market Attractiveness Index
15.3 MEA Protein Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
15.4 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Country
15.5 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
15.6 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Service
15.7 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Expression System
15.8 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Protein Type
15.9 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
15.10 MEA Protein Contract Manufacturing Market Size Estimation and Forecast by End-users
15.11 GCC Protein Contract Manufacturing Market Analysis
15.12 South Africa Protein Contract Manufacturing Market Analysis
15.13 Rest of MEA Protein Contract Manufacturing Market Analysis

16 Company Profiles
16.1 Abzena
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financials
16.1.3.1 Revenue, 2022-2025 (US$ Million)
16.1.3.2 R&D, 2022-2025 (US$ Million)
16.1.3.3 Business Segment Market Shares (%), 2025
16.1.3.4 Geographic Segment Market Shares (%), 2025
16.1.4 Service Benchmarking
16.1.5 Strategic Outlook
16.2 3P BIOVIAN
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financials
16.2.3.1 Revenue, 2022-2025 (US$ Million)
16.2.3.2 R&D, 2022-2025 (US$ Million)
16.2.3.3 Business Segment Market Shares (%), 2025
16.2.3.4 Geographic Segment Market Shares (%), 2025
16.2.4 Service Benchmarking
16.2.5 Strategic Outlook
16.3 AGC Biologics
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financials
16.3.3.1 Revenue, 2022-2025 (US$ Million)
16.3.3.2 R&D, 2022-2025 (US$ Million)
16.3.3.3 Business Segment Market Shares (%), 2025
16.3.3.4 Geographic Segment Market Shares (%), 2025
16.3.4 Service Benchmarking
16.3.5 Strategic Outlook
16.4 Boehringer Ingelheim BioXcellence
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financials
16.4.3.1 Revenue, 2022-2025 (US$ Million)
16.4.3.2 R&D, 2022-2025 (US$ Million)
16.4.3.3 Business Segment Market Shares (%), 2025
16.4.3.4 Geographic Segment Market Shares (%), 2025
16.4.4 Service Benchmarking
16.4.5 Strategic Outlook
16.5 Curia Global, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financials
16.5.3.1 Revenue, 2022-2025 (US$ Million)
16.5.3.2 R&D, 2022-2025 (US$ Million)
16.5.3.3 Business Segment Market Shares (%), 2025
16.5.3.4 Geographic Segment Market Shares (%), 2025
16.5.4 Service Benchmarking
16.5.5 Strategic Outlook
16.6 Cytovance Biologics
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financials
16.6.3.1 Revenue, 2022-2025 (US$ Million)
16.6.3.2 R&D, 2022-2025 (US$ Million)
16.6.3.3 Business Segment Market Shares (%), 2025
16.6.3.4 Geographic Segment Market Shares (%), 2025
16.6.4 Service Benchmarking
16.6.5 Strategic Outlook
16.7 FUJIFILM Diosynth Biotechnologies
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financials
16.7.3.1 Revenue, 2022-2025 (US$ Million)
16.7.3.2 R&D, 2022-2025 (US$ Million)
16.7.3.3 Business Segment Market Shares (%), 2025
16.7.3.4 Geographic Segment Market Shares (%), 2025
16.7.4 Service Benchmarking
16.7.5 Strategic Outlook
16.8 KBI Biopharma
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financials
16.8.3.1 Revenue, 2022-2025 (US$ Million)
16.8.3.2 R&D, 2022-2025 (US$ Million)
16.8.3.3 Business Segment Market Shares (%), 2025
16.8.3.4 Geographic Segment Market Shares (%), 2025
16.8.4 Service Benchmarking
16.8.5 Strategic Outlook
16.9 Lonza Group AG
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financials
16.9.3.1 Revenue, 2022-2025 (US$ Million)
16.9.3.2 R&D, 2022-2025 (US$ Million)
16.9.3.3 Business Segment Market Shares (%), 2025
16.9.3.4 Geographic Segment Market Shares (%), 2025
16.9.4 Service Benchmarking
16.9.5 Strategic Outlook
16.10 Catalent, Inc. (Novo Holdings)
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financials
16.10.3.1 Revenue, 2022-2025 (US$ Million)
16.10.3.2 R&D, 2022-2025 (US$ Million)
16.10.3.3 Business Segment Market Shares (%), 2025
16.10.3.4 Geographic Segment Market Shares (%), 2025
16.10.4 Service Benchmarking
16.10.5 Strategic Outlook
16.11 ProBioGen AG
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Financials
16.11.3.1 Revenue, 2022-2025 (US$ Million)
16.11.3.2 R&D, 2022-2025 (US$ Million)
16.11.3.3 Business Segment Market Shares (%), 2025
16.11.3.4 Geographic Segment Market Shares (%), 2025
16.11.4 Service Benchmarking
16.11.5 Strategic Outlook
16.12 Rentschler Biopharma SE
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Financials
16.12.3.1 Revenue, 2022-2025 (US$ Million)
16.12.3.2 R&D, 2022-2025 (US$ Million)
16.12.3.3 Business Segment Market Shares (%), 2025
16.12.3.4 Geographic Segment Market Shares (%), 2025
16.12.4 Service Benchmarking
16.12.5 Strategic Outlook
16.13 Samsung Biologics Co., Ltd.
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Financials
16.13.3.1 Revenue, 2022-2025 (US$ Million)
16.13.3.2 R&D, 2022-2025 (US$ Million)
16.13.3.3 Business Segment Market Shares (%), 2025
16.13.3.4 Geographic Segment Market Shares (%), 2025
16.13.4 Service Benchmarking
16.13.5 Strategic Outlook
16.14 Syngene International Limited
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Financials
16.14.3.1 Revenue, 2022-2025 (US$ Million)
16.14.3.2 R&D, 2022-2025 (US$ Million)
16.14.3.3 Business Segment Market Shares (%), 2025
16.14.3.4 Geographic Segment Market Shares (%), 2025
16.14.4 Service Benchmarking
16.14.5 Strategic Outlook
16.15 Thermo Fisher Scientific Inc. (Patheon Pharma Services)
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financials
16.15.3.1 Revenue, 2022-2025 (US$ Million)
16.15.3.2 R&D, 2022-2025 (US$ Million)
16.15.3.3 Business Segment Market Shares (%), 2025
16.15.3.4 Geographic Segment Market Shares (%), 2025
16.15.4 Service Benchmarking
16.15.5 Strategic Outlook
16.16 Wacker Biotech GmbH
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Financials
16.16.3.1 Revenue, 2022-2025 (US$ Million)
16.16.3.2 R&D, 2022-2025 (US$ Million)
16.16.3.3 Business Segment Market Shares (%), 2025
16.16.3.4 Geographic Segment Market Shares (%), 2025
16.16.4 Service Benchmarking
16.16.5 Strategic Outlook
16.17 WuXi Biologics
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Financials
16.17.3.1 Revenue, 2022-2025 (US$ Million)
16.17.3.2 R&D, 2022-2025 (US$ Million)
16.17.3.3 Business Segment Market Shares (%), 2025
16.17.3.4 Geographic Segment Market Shares (%), 2025
16.17.4 Service Benchmarking
16.17.5 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

 

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Protein Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 3 Preclinical / Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 4 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 5 Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 6 Protein Drug Substance Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 7 Protein Drug Product Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 8 Development and Analytical Services Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 9 Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 10 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 11 Microbial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 12 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 13 Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 14 Monoclonal Antibodies and Antibody Fragments Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 15 Fusion Proteins Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 16 Enzymes Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 17 Hormones and Growth Factors Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 18 Cytokines and Interferons Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 20 Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 21 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 22 Autoimmune and Inflammatory Disorders Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 23 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 24 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 25 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 26 Other Therapeutic Area Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 27 Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 28 Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 29 Biotechnology Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 30 Biosimilar Manufacturers Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 31 Academic and Research Institutions Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 32 Protein Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 33 North America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 34 North America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 35 North America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 36 North America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 37 North America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 38 North America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 39 North America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 40 U.S. Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 41 Canada Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 42 Europe Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 43 Europe Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 44 Europe Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 45 Europe Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 46 Europe Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 47 Europe Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 48 Europe Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 49 Germany Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 50 UK Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 51 France Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 52 Italy Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 53 Rest of Europe Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 54 Asia Pacific Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 55 Asia Pacific Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 56 Asia Pacific Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 57 Asia Pacific Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 58 Asia Pacific Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 59 Asia Pacific Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 60 Asia Pacific Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 61 Japan Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 62 China Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 63 India Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 64 Australia Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 65 Rest of Asia Pacific Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 66 Latin America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 67 Latin America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 68 Latin America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 69 Latin America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 70 Latin America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 71 Latin America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 72 Latin America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 73 Brazil Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 74 Mexico Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 75 Rest of Latin America Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 76 MEA Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 77 MEA Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 78 MEA Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 79 MEA Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 80 MEA Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 81 MEA Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 82 MEA Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 83 GCC Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 84 South Africa Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 85 Rest of MEA Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 86 Abzena: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Abzena: Service Benchmarking
Table 88 Abzena: Strategic Outlook
Table 89 3P BIOVIAN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 3P BIOVIAN: Service Benchmarking
Table 91 3P BIOVIAN: Strategic Outlook
Table 92 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 AGC Biologics: Service Benchmarking
Table 94 AGC Biologics: Strategic Outlook
Table 95 Boehringer Ingelheim BioXcellence: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Boehringer Ingelheim BioXcellence: Service Benchmarking
Table 97 Boehringer Ingelheim BioXcellence: Strategic Outlook
Table 98 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Curia Global, Inc.: Service Benchmarking
Table 100 Curia Global, Inc.: Strategic Outlook
Table 101 Cytovance Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Cytovance Biologics: Service Benchmarking
Table 103 Cytovance Biologics: Strategic Outlook
Table 104 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 106 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 107 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 KBI Biopharma: Service Benchmarking
Table 109 KBI Biopharma: Strategic Outlook
Table 110 Lonza Group AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Lonza Group AG: Service Benchmarking
Table 112 Lonza Group AG: Strategic Outlook
Table 113 Catalent, Inc. (Novo Holdings): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Catalent, Inc. (Novo Holdings): Service Benchmarking
Table 115 Catalent, Inc. (Novo Holdings): Strategic Outlook
Table 116 ProBioGen AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 ProBioGen AG: Service Benchmarking
Table 118 ProBioGen AG: Strategic Outlook
Table 119 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Rentschler Biopharma SE: Service Benchmarking
Table 121 Rentschler Biopharma SE: Strategic Outlook
Table 122 Samsung Biologics Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Samsung Biologics Co., Ltd.: Service Benchmarking
Table 124 Samsung Biologics Co., Ltd.: Strategic Outlook
Table 125 Syngene International Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Syngene International Limited: Service Benchmarking
Table 127 Syngene International Limited: Strategic Outlook
Table 128 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Service Benchmarking
Table 130 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Strategic Outlook
Table 131 Wacker Biotech GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Wacker Biotech GmbH: Service Benchmarking
Table 133 Wacker Biotech GmbH: Strategic Outlook
Table 134 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 WuXi Biologics: Service Benchmarking
Table 136 WuXi Biologics: Strategic Outlook

List of Figures
Figure 1 Protein Contract Manufacturing Market Segmentation
Figure 2 Protein Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
Figure 3 Protein Contract Manufacturing Market by Service: Market Attractiveness Index
Figure 4 Protein Contract Manufacturing Market by Expression System: Market Attractiveness Index
Figure 5 Protein Contract Manufacturing Market by Protein Type: Market Attractiveness Index
Figure 6 Protein Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
Figure 7 Protein Contract Manufacturing Market by End-users: Market Attractiveness Index
Figure 8 Protein Contract Manufacturing Market Attractiveness Index by Region
Figure 9 Protein Contract Manufacturing Market: Market Dynamics
Figure 10 Protein Contract Manufacturing Market: Porter’s Five Forces Analysis
Figure 11 Protein Contract Manufacturing Market: PEST Analysis
Figure 12 Protein Contract Manufacturing Market Attractiveness Index by Scale of Operation
Figure 13 Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 14 Protein Contract Manufacturing Market Share Forecast by Scale of Operation, 2026, 2031, 2036 (%)
Figure 15 Preclinical / Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 16 Preclinical / Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 17 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 18 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 19 Protein Contract Manufacturing Market Attractiveness Index by Service
Figure 20 Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 21 Protein Contract Manufacturing Market Share Forecast by Service, 2026, 2031, 2036 (%)
Figure 22 Protein Drug Substance Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 23 Protein Drug Substance Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Protein Drug Product Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 25 Protein Drug Product Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Development and Analytical Services Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 27 Development and Analytical Services Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 28 Protein Contract Manufacturing Market Attractiveness Index by Expression System
Figure 29 Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 30 Protein Contract Manufacturing Market Share Forecast by Expression System, 2026, 2031, 2036 (%)
Figure 31 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 32 Mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Microbial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 34 Microbial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 36 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Protein Contract Manufacturing Market Attractiveness Index by Protein Type
Figure 38 Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 39 Protein Contract Manufacturing Market Share Forecast by Protein Type, 2026, 2031, 2036 (%)
Figure 40 Monoclonal Antibodies and Antibody Fragments Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 41 Monoclonal Antibodies and Antibody Fragments Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 42 Fusion Proteins Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 43 Fusion Proteins Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Enzymes Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 45 Enzymes Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Hormones and Growth Factors Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 47 Hormones and Growth Factors Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Cytokines and Interferons Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 49 Cytokines and Interferons Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Protein Contract Manufacturing Market Attractiveness Index by Therapeutic Area
Figure 53 Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 54 Protein Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026, 2031, 2036 (%)
Figure 55 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 56 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Autoimmune and Inflammatory Disorders Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 58 Autoimmune and Inflammatory Disorders Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 60 Metabolic Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 62 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 63 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 64 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 65 Other Therapeutic Area Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 66 Other Therapeutic Area Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 67 Protein Contract Manufacturing Market Attractiveness Index by End-users
Figure 68 Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 69 Protein Contract Manufacturing Market Share Forecast by End-users, 2026, 2031, 2036 (%)
Figure 70 Pharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 71 Pharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 72 Biotechnology Companies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 73 Biotechnology Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 74 Biosimilar Manufacturers Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 75 Biosimilar Manufacturers Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 76 Academic and Research Institutions Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 77 Academic and Research Institutions Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 78 Protein Contract Manufacturing Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR %)
Figure 79 Protein Contract Manufacturing Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 80 Protein Contract Manufacturing Market by Region, 2026-2036 (US$ Bn, AGR %)
Figure 81 North America Protein Contract Manufacturing Market Attractiveness Index
Figure 82 North America Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 83 North America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 84 North America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 85 North America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 86 North America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 87 North America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 88 North America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 89 North America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 90 U.S. Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 91 Canada Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 92 Europe Protein Contract Manufacturing Market Attractiveness Index
Figure 93 Europe Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 94 Europe Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 95 Europe Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 96 Europe Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 97 Europe Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 98 Europe Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 99 Europe Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 100 Europe Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 101 Germany Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 102 UK Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 103 France Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 104 Italy Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 105 Rest of Europe Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 106 Asia Pacific Protein Contract Manufacturing Market Attractiveness Index
Figure 107 Asia Pacific Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 108 Asia Pacific Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 109 Asia Pacific Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 110 Asia Pacific Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 111 Asia Pacific Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 112 Asia Pacific Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 113 Asia Pacific Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 114 Asia Pacific Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 115 Japan Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 116 China Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 117 India Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 118 Australia Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 119 Rest of Asia Pacific Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 120 Latin America Protein Contract Manufacturing Market Attractiveness Index
Figure 121 Latin America Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 122 Latin America Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 123 Latin America Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 124 Latin America Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 125 Latin America Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 126 Latin America Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 127 Latin America Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 128 Latin America Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 129 Brazil Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 130 Mexico Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 131 Rest of Latin America Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 132 MEA Protein Contract Manufacturing Market Attractiveness Index
Figure 133 MEA Protein Contract Manufacturing Market by Region, 2026, 2031, 2036 (US$ Million)
Figure 134 MEA Protein Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 135 MEA Protein Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ Million, AGR %)
Figure 136 MEA Protein Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 137 MEA Protein Contract Manufacturing Market Forecast by Expression System, 2026-2036 (US$ Million, AGR %)
Figure 138 MEA Protein Contract Manufacturing Market Forecast by Protein Type, 2026-2036 (US$ Million, AGR %)
Figure 139 MEA Protein Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 140 MEA Protein Contract Manufacturing Market Forecast by End-users, 2026-2036 (US$ Million, AGR %)
Figure 141 GCC Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 142 South Africa Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 143 Rest of MEA Protein Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 144 Abzena: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 145 Abzena: Regional Market Shares (%), 2025
Figure 146 Abzena: R&D, 2022-2025 (US$ Million, AGR %)
Figure 147 Abzena: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 148 Abzena: Regional Market Shares (%), 2025
Figure 149 Abzena: R&D, 2022-2025 (US$ Million, AGR %)
Figure 150 3P BIOVIAN: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 151 3P BIOVIAN: Regional Market Shares (%), 2025
Figure 152 3P BIOVIAN: R&D, 2022-2025 (US$ Million, AGR %)
Figure 153 AGC Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 154 AGC Biologics: Regional Market Shares (%), 2025
Figure 155 AGC Biologics: R&D, 2022-2025 (US$ Million, AGR %)
Figure 156 Boehringer Ingelheim BioXcellence: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 157 Boehringer Ingelheim BioXcellence: Regional Market Shares (%), 2025
Figure 158 Boehringer Ingelheim BioXcellence: R&D, 2022-2025 (US$ Million, AGR %)
Figure 159 Curia Global, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 160 Curia Global, Inc.: Regional Market Shares (%), 2025
Figure 161 Curia Global, Inc.: R&D, 2022-2025 (US$ Million, AGR %)
Figure 162 Cytovance Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 163 Cytovance Biologics: Regional Market Shares (%), 2025
Figure 164 Cytovance Biologics: R&D, 2022-2025 (US$ Million, AGR %)
Figure 165 FUJIFILM Diosynth Biotechnologies: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 166 FUJIFILM Diosynth Biotechnologies: Regional Market Shares (%), 2025
Figure 167 FUJIFILM Diosynth Biotechnologies: R&D, 2022-2025 (US$ Million, AGR %)
Figure 168 KBI Biopharma: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 169 KBI Biopharma: Regional Market Shares (%), 2025
Figure 170 KBI Biopharma: R&D, 2022-2025 (US$ Million, AGR %)
Figure 171 Lonza Group AG: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 172 Lonza Group AG: Regional Market Shares (%), 2025
Figure 173 Lonza Group AG: R&D, 2022-2025 (US$ Million, AGR %)
Figure 174 Catalent, Inc. (Novo Holdings): Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 175 Catalent, Inc. (Novo Holdings): Regional Market Shares (%), 2025
Figure 176 Catalent, Inc. (Novo Holdings): R&D, 2022-2025 (US$ Million, AGR %)
Figure 177 ProBioGen AG: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 178 ProBioGen AG: Regional Market Shares (%), 2025
Figure 179 ProBioGen AG: R&D, 2022-2025 (US$ Million, AGR %)
Figure 180 Rentschler Biopharma SE: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 181 Rentschler Biopharma SE: Regional Market Shares (%), 2025
Figure 182 Rentschler Biopharma SE: R&D, 2022-2025 (US$ Million, AGR %)
Figure 183 Samsung Biologics Co., Ltd.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 184 Samsung Biologics Co., Ltd.: Regional Market Shares (%), 2025
Figure 185 Samsung Biologics Co., Ltd.: R&D, 2022-2025 (US$ Million, AGR %)
Figure 186 Syngene International Limited: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 187 Syngene International Limited: Regional Market Shares (%), 2025
Figure 188 Syngene International Limited: R&D, 2022-2025 (US$ Million, AGR %)
Figure 189 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 190 Thermo Fisher Scientific Inc. (Patheon Pharma Services): Regional Market Shares (%), 2025
Figure 191 Thermo Fisher Scientific Inc. (Patheon Pharma Services): R&D, 2022-2025 (US$ Million, AGR %)
Figure 192 Wacker Biotech GmbH: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 193 Wacker Biotech GmbH: Regional Market Shares (%), 2025
Figure 194 Wacker Biotech GmbH: R&D, 2022-2025 (US$ Million, AGR %)
Figure 195 WuXi Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 196 WuXi Biologics: Regional Market Shares (%), 2025
Figure 197 WuXi Biologics: R&D, 2022-2025 (US$ Million, AGR %)

 

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Visiongain社の ヘルスケアと医薬・化学品分野 での最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

当社ご利用のメリット
  1. ① お探しの情報に合わせてレポートをご紹介
  2. ② レポートで不足している情報はカスタマイズで対応可能
  3. ③ 特許情報、海外の法規制の取り組みなどディープな調査も対応可能
  4. ④ 円貨で請求書払い＆万全のアフターフォロー

 

2026/10/27　10:25

158.64 円

177.60 円

214.31 円

ページTOPに戻る

株式会社 データリソース　Data Resource, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430


A member of CORSS Business Producers Inc.
データリソースは2025年5月より
CROSS Business Producers株式会社 の100%子会社になりました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCE, Inc. ALL RIGHTS RESERVED.